{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:53:37Z","timestamp":1771570417372,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"BAT","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>For novel tobacco products that potentially reduce the risk of tobacco harm, post-market surveillance is important to observe population usage and behaviours associated with everyday use. This pilot study was performed to examine the use of tobacco products in three Japanese urban regions.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This study was a cross-sectional epidemiological survey administered in Sendai, Tokyo and Osaka, Japan, from May 19th to June 25th, 2018. Participants were selected with a three-stage probability random sampling process that first identified primary sampling units, then households and finally individuals. Eligible participants were aged at least 20 years who were willing to participate after information about the study was provided. People younger than 20 years and those living in institutions were excluded. Questionnaires were paper based and administered door to door.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Responses were obtained from 4154 participants. Sixty-five percent self-reported being never, 19% current and 16% former users of any tobacco product at the time of the survey. Combustible tobacco products (almost all being cigarette) were used most (16%) followed by HTPs (5%). In the categories of combustible tobacco users and HTP users, 70% and 16%, respectively, used these products exclusively. Dual use was reported by 11% of respondents. Compared with 12 months before the survey, 12% of sole combustible tobacco products users were using HTPs exclusively or as dual users and 6% had quit tobacco products completely; 94% of sole HTP users remained sole users and 4% had quit tobacco products completely; and amongst dual users 12% had reverted to exclusive use of combustible tobacco products, 14% had switched to sole use of HTPs and 4% had quit tobacco products completely.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>HTPs seem to be accepted as an alternative tobacco product amongst combustible tobacco users. Given complex findings for dual use, improved understanding of the motivations underlying this behaviour would be of interest.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12954-020-00374-3","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T23:05:04Z","timestamp":1590447904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Results from a 2018 cross-sectional survey in Tokyo, Osaka and Sendai to assess tobacco and nicotine product usage after the introduction of heated tobacco products (HTPs) in Japan"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0757-5950","authenticated-orcid":false,"given":"Jason","family":"Adamson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Kanitscheider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar M.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Beyerlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoga Keralapura","family":"Bhagavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"key":"374_CR1","doi-asserted-by":"publisher","first-page":"739","DOI":"10.12688\/f1000research.18920.1","volume":"8","author":"J Adamson","year":"2019","unstructured":"Adamson J, Kanitscheider C, Prasad K, Camacho OM, Beyerlein E, Bhagavan YK, Proctor C, Murphy J. Protocol for a Japanese nationwide repeated cross-sectional study to assess tobacco and nicotine product use behaviour after market introduction of Tobacco Heating Products (THPs). F1000 Research. 2019;8:739.","journal-title":"F1000 Research"},{"issue":"5","key":"374_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1037\/0278-6133.10.5.360","volume":"10","author":"L Biener","year":"1991","unstructured":"Biener L, Abrams DB. The Contemplation Ladder: Validation of a Measure of Readiness to Consider Smoking Cessation. Health Psychol. 1991;10(5):360\u20135.","journal-title":"Health Psychol."},{"issue":"Suppl 1","key":"374_CR3","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1093\/ntr\/ntq038","volume":"12","author":"R Borland","year":"2010","unstructured":"Borland R, Yong H-H, O\u2019Connor RJ, Hyland A, Thompson ME. The reliability and predictive validity of the Heaviness of Smoking Index and its two components: Findings from the International Tobacco Control Four Country study. Nicotine Tob Res. 2010;12(Suppl 1):S45\u201350. https:\/\/doi.org\/10.1093\/ntr\/ntq038.","journal-title":"Nicotine Tob Res"},{"key":"374_CR4","unstructured":"Cancer Research UK, 2020. Our policy on e-cigarettes. https:\/\/www.cancerresearchuk.org\/about-us\/we-develop-policy\/our-policy-on-preventing-cancer\/our-policy-on-tobacco-control-and-cancer\/our-policy-on-e-cigarettes (Accessed 28 Feb 2020)."},{"key":"374_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.yrtph.2017.09.009","volume":"93","author":"D Eaton","year":"2018","unstructured":"Eaton D, Jakaj B, Forster M, et al. Assessment of tobacco heating product THP1.0. Part 2:product design, operation and thermophysical characterisation. Regulatory Toxicology and Pharmacology. 2018;93:4\u201313.","journal-title":"Regulatory Toxicology and Pharmacology."},{"key":"374_CR6","unstructured":"FDA - Food and Drug Administration. Modified Risk Tobacco Product Applications (Draft Guidance) 2012 [Available from: https:\/\/www.fda.gov\/downloads\/TobaccoProducts\/GuidanceComplianceRegulatoryInformation\/UCM297751.pdf. Accessed on 18 Jan 2018]."},{"key":"374_CR7","first-page":"2016","volume-title":"International Smoking Statistics. A collection of worldwide historical data. Web edition Sutton","author":"B Forey","year":"2016","unstructured":"Forey B, Hamling J, Hamling J, Lee P. International Smoking Statistics. A collection of worldwide historical data. Web edition Sutton. Surrey: PN Lee Statistics and Computing Ltd; 2016. p. 2016."},{"key":"374_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.yrtph.2017.10.006","volume":"93","author":"M Forster","year":"2018","unstructured":"Forster M, Fiebelkorn S, Yurteri C, Mariner D, Liu C, Wright C, et al. Assessment of Novel Tobacco Heating Product Thp1.0. Part 3: Comprehensive Chemical Characterisation of Harmful and Potentially Harmful Aerosol Emissions. Regul Toxicol Pharmacol. 2018;93:14\u201333.","journal-title":"Regul Toxicol Pharmacol."},{"issue":"9","key":"374_CR9","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/ntr\/nty104","volume":"21","author":"Nathan Gale","year":"2018","unstructured":"Gale N, McEwan M, Eldridge A, et al. Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects. Nicotine Tob Res. 2019;21(9):1220\u20131227.","journal-title":"Nicotine & Tobacco Research"},{"key":"374_CR10","doi-asserted-by":"publisher","first-page":"s70","DOI":"10.1136\/tobaccocontrol-2018-054322","volume":"27","author":"EC Hair","year":"2018","unstructured":"Hair EC, Bennett M, Sheen E, et al. Examining perceptions about IQOS heated tobacco product: consumer studies in Japan and Switzerland. Tob Control. 2018;27:s70\u20133.","journal-title":"Tob Control"},{"key":"374_CR11","unstructured":"JTI 2018 - Japan Tobacco Incorporation. JT\u2019s Annual Survey 2018 [Available from: https:\/\/www.jt.com\/media\/news\/2018\/pdf\/20180730_02.pdf."},{"key":"374_CR12","doi-asserted-by":"crossref","unstructured":"Mallock N, Boss L, Rurk R, et al. Levels of selected analytes in the emissions of \u201cheat not burn\u201d tobacco products that are relevent to assess human health risks. Archives of Toxiciology. 2018.","DOI":"10.1007\/s00204-018-2215-y"},{"key":"374_CR13","volume-title":"Ecigarettes: an Evidence Update. A report commissioned by Public Health England","author":"A McNeill","year":"2015","unstructured":"McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H. Ecigarettes: an Evidence Update. A report commissioned by Public Health England; 2015."},{"key":"374_CR14","unstructured":"MHLW, 2016 - Ministry of Health, Labour and Welfare (MHLW) 2016; https:\/\/www.mhlw.go.jp\/english\/database\/db-hss\/dl\/report_gaikyo_2016.pdf. Accessed on 10 Dec 2018."},{"key":"374_CR15","volume-title":"Examining the state of Japan\u2019s \u201cheat-not-burn cigarette\u201d market","author":"M Mori","year":"2016","unstructured":"Mori M. Examining the state of Japan\u2019s \u201cheat-not-burn cigarette\u201d market. Japan: Credit Suisse; 2016."},{"issue":"11","key":"374_CR16","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.3390\/ijerph111010345","volume":"2014","author":"Pepper","year":"2014","unstructured":"Pepper, et al. Reasons for Starting and Stopping Electronic Cigarette Use. Int J Environ Res Public Health. 2014;2014(11):10345\u201361.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"374_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/pds.3891","volume":"25","author":"Public Policy Committee International Society of Pharmacoepidemiology (ISoP)","year":"2016","unstructured":"Public Policy Committee International Society of Pharmacoepidemiology (ISoP). Guidelines for Good Pharmacoepidemiology Practice (GPP). Pharmacoepidemiol Drug Saf. 2016;25(1):2\u201310.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"374_CR18","unstructured":"Reuters, 2018: Japan Tobacco to launch new smokeless product this year [Available from: https:\/\/uk.reuters.com\/article\/japan-tobacco-results\/japan-tobacco-to-launch-new-smokeless-product-this-year-idUKL4N1PO1FO, Accessed on: 25 July 2018]."},{"key":"374_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.12688\/f1000research.17635.2","volume":"8","author":"F Riahi","year":"2019","unstructured":"Riahi F, Rajkumar S, Yach D. Tobacco smoking and nicotine delivery alternatives: patterns of product use and perceptions in 13 countries [version 2; peer review: 2 approved]. F1000Research. 2019;8:80.","journal-title":"F1000Research"},{"key":"374_CR20","volume-title":"Diffusion of innovations","author":"EM Rogers","year":"2003","unstructured":"Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003.","edition":"5"},{"key":"374_CR21","volume-title":"Nicotine without smoke: Tobacco harm reduction. RCP policy: public health and health inequality, 28 April 2016","author":"Royal College of Physicians (RCP)","year":"2016","unstructured":"Royal College of Physicians (RCP) 2016. Nicotine without smoke: Tobacco harm reduction. RCP policy: public health and health inequality, 28 April 2016."},{"key":"374_CR22","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/ntr\/ntv003","volume":"2015","author":"Rutten","year":"2015","unstructured":"Rutten, et al. Use of E-Cigarettes Among Current Smokers: Association Among Reasons for Use, Quit Intentions, and Current Tobacco Use. Nicotine & Tobacco Research. 2015;2015:1228\u201334.","journal-title":"Nicotine & Tobacco Research"},{"issue":"2","key":"374_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1086\/268785","volume":"47","author":"Charles T. Salmon","year":"1983","unstructured":"Salmon CT and Nichols JS. The Next-Birthday Method of Respondent Selection. Public Opinion Quarterly, Volume 47, Issue 2, SUMMER 1983, Pages 270\u2013276. https:\/\/doi.org\/10.1086\/268785.","journal-title":"Public Opinion Quarterly"},{"key":"374_CR24","first-page":"S27eS47","volume":"81","author":"JP Schaller","year":"2016","unstructured":"Schaller JP, Keller D, Poget L, Pratte P, Kaelin E, McHugh D, Cudazzo G, Smart D, Tricker AR, Gautier L, Yerly M, Pires RR, Le Bouhellec S, Ghosh D, Hofer I, Garcia E, Vanscheeuwijck P, Maeder S. Evaluation of the Tobacco Heating System 2.2. Part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul. Toxicol. Pharmacol. 2016;81:S27eS47.","journal-title":"Regul. Toxicol. Pharmacol"},{"key":"374_CR25","unstructured":"Simonavuicius E, McNeill A, Shahab L, Brose L.S. Heat-not-burn tobacco products: a systematic literature review. Tob Control 2018;0:1-13."},{"key":"374_CR26","doi-asserted-by":"publisher","first-page":"S17eS26","DOI":"10.1016\/j.yrtph.2016.07.006","volume":"81","author":"MR Smith","year":"2016","unstructured":"Smith MR, Clark B, Luedicke F, Schaller JP, Vanscheeuwijck P, Hoeng J, Peitsch MC. Evaluation of the tobacco heating system 2.2. Part 1: description of the system and the scientific assessment program. Regul. Toxicol. Pharmacol. 2016;81:S17eS26.","journal-title":"Regul. Toxicol. Pharmacol"},{"key":"374_CR27","volume-title":"Smoking trends in Japan from 2008-2017: results from the national health and wellness survey.","author":"N Sternbach","year":"2018","unstructured":"Sternbach N, Annunziata K, Fukuda T, Chen Y, Stankus AP. Smoking trends in Japan from 2008-2017: results from the national health and wellness survey. Tokyo: Poster presented at the ISPOR Asia Pacific 2018, 8-11 September 2018; 2018."},{"key":"374_CR28","doi-asserted-by":"publisher","unstructured":"Stoklosa M, Cahn Z, Liber A, et al. Effect of IQOS introduction on cigarette sales: evidence of decline and replacement. Tobacco Control Published Online First. 2019. https:\/\/doi.org\/10.1136\/tobaccocontrol-2019-054998.","DOI":"10.1136\/tobaccocontrol-2019-054998"},{"issue":"e1","key":"374_CR29","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1136\/tobaccocontrol-2017-053947","volume":"27","author":"Takahiro Tabuchi","year":"2017","unstructured":"Tabuchi T, Gallus S, Shinozaki T, Nakaya T, Kunugita N, Colwell B. Heat-not-burn tobacco product use in Japan: Its prevalence, predictors and perceived symptoms from exposure to secondhand heat-not-burn tobacco aerosol. Tobacco Control Published Online First: 16 December 2017. 2017. https:\/\/doi.org\/10.1136\/tobaccocontrol-2017-053947.","journal-title":"Tobacco Control"},{"key":"374_CR30","unstructured":"Tobacco Atlas: Regulating Novel Products (2018). Accessed June 20, 2019. https:\/\/tobaccoatlas.org\/topic\/regulating-novel-products\/."},{"key":"374_CR31","unstructured":"Uranaka, T.; Ando, R. Philip Morris Aims to Revive Japan Sales with Cheaper Heat-Not-Burn Tobacco. Reuters. Tokyo. 2018. Available online: https:\/\/www.reuters.com\/article\/us-pmi-japan\/philip-morris-aimsto- revive-japan-sales-with-cheaper-heat-not-burn-tobacco-idUSKCN1MX06E (accessed on 14 January 2020)."},{"issue":"20","key":"374_CR32","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Jama. 2013;310(20):2191\u20134.","journal-title":"Jama."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-020-00374-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00374-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T23:22:45Z","timestamp":1621984965000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-020-00374-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1186\/s12954-020-00374-3","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is an epidemiological population survey and is conducted in accordance with the most current versions of the Declaration of Helsinki [], the guidelines for Good Epidemiological Practice [] and local laws and regulations. The study is conducted in accordance with the most current version of Marketing Research Guideline and Personal Information Protection Guideline that JMRA (Japan Marketing Research Association) have established. Those guidelines also comply with ICC\/ESOMAR codes of conduct. At the beginning of April 2018, an independent ethics committee (IEC) in Japan, consisting of 9 members (clinical and legal) were informed about the intended data collection and all required documents were provided, including protocol, participant information letter and questionnaire. The IEC, based at Kitamachi Clinic in Tokyo, reviewed the study documents and approved study conduct on 17th April 2018 before fieldwork commenced. This study did not actively ask for adverse events\/effects (AEs) or product complaints which occurred during use of the HTP <i>glo,<\/i> but interviewers were instructed to record anything reported by participants; during this study, no participants spontaneously reported any AE or product complaints related to <i>glo<\/i> during questionnaire distribution or collection by interviewers. During fieldwork, participants were informed about the study purpose, their requested tasks, time of involvement, data confidentiality and data protection, incentive and contact details in case of questions; by completing the paper questionnaire, the participant was informed they were implicitly giving consent to participate in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants were informed prior to giving their consent to participate in this study that grouped data would be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors are full time employees of British American Tobacco (BAT) Research and Development UK, or of Kantar Germany (Health Division), who conducted the study on behalf of BAT. Nippon Research Centre (NRC) were the local fieldwork providers, working with Kantar Japan.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}